<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04823949</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00090951</org_study_id>
    <nct_id>NCT04823949</nct_id>
  </id_info>
  <brief_title>Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring</brief_title>
  <acronym>PHANTOM</acronym>
  <official_title>Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prisma Health-Upstate</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>South Carolina Telehealth Alliance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Babyscripts</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Prisma Health-Upstate</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A large segment of our patient population is diagnosed with hypertensive disorders of&#xD;
      pregnancy, including gestational hypertension and pre-eclampsia. New ACOG guidelines&#xD;
      recommend postpartum monitoring of blood pressures via blood pressure checks on day 3&#xD;
      postpartum and between days 7-10 postpartum. Our purpose is to compare the effectiveness of&#xD;
      using a Bluetooth-enabled home blood pressure monitoring platform to the standard postpartum&#xD;
      office-based blood pressure monitoring in performing the recommended postpartum follow-up for&#xD;
      patients with hypertensive disorders of pregnancy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      While inpatient during the postpartum period, patients will be identified who were diagnosed&#xD;
      with hypertensive disorders of pregnancy antepartum, intrapartum, or postpartum. These&#xD;
      patients will be recruited prior to discharge home. This will be a randomized control trial,&#xD;
      non-blinded. The study group will receive a mobile app for postpartum education and an&#xD;
      integrated Wi-Fi connected blood pressure cuff for at-home monitoring for 16 days postpartum.&#xD;
      The home BP monitoring will occur twice a day and study team will check the BPs twice a day&#xD;
      and intervene by phone or text if necessary. The control group will be scheduled for blood&#xD;
      pressure checks at the clinic between days 7-10. These groups will be compared with regard to&#xD;
      identification of severe blood pressures (&gt;/= 160/100), adherence to ACOG guidelines for&#xD;
      blood pressure monitoring, timing of the identification and treatment of severe blood&#xD;
      pressures, readmissions, and patient satisfaction.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">April 15, 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Control arm: will be scheduled an in-office blood pressure check 7-10 days postpartum Intervention arm: will receive a blood pressure cuff and app with which to monitor their blood pressures at home for 16 days postpartum</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence to ACOG guideline of postpartum blood pressure check within 7-10 days postpartum</measure>
    <time_frame>10 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment of severe range blood pressures</measure>
    <time_frame>16 days</time_frame>
    <description>timing of the identification and treatment of severe blood pressures</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmissions</measure>
    <time_frame>16 days</time_frame>
    <description>Number of readmissions in each arm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction via survey</measure>
    <time_frame>21 days</time_frame>
    <description>Satisfaction of patients participating in each arm determined via survey</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gestational Hypertension</condition>
  <condition>Preeclampsia</condition>
  <condition>Chronic Hypertension With Pre-Eclampsia Complicating Childbirth (Diagnosis)</condition>
  <condition>HELLP Syndrome</condition>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patient will be scheduled for a blood pressure check in the office 7-10 days postpartum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient will receive a Babyscripts blood pressure cuff(brand: A&amp;D Medical) and Babyscripts MyJourney phone app with which to monitor their blood pressures twice daily for 16 days after discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Home blood pressure monitoring</intervention_name>
    <description>See arm description</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must have delivered an infant either at Greenville Memorial Hospital or MUSC&#xD;
             and be willing and able to follow-up with her respective institution.&#xD;
&#xD;
          -  Patient must have been diagnosed with a hypertensive disorder of pregnancy in the&#xD;
             antepartum, intrapartum, or postpartum period.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;18 years of age&#xD;
&#xD;
          -  BMI &gt;40 (due to limitations in BP cuff size through BabyScripts)&#xD;
&#xD;
          -  non English-speaking&#xD;
&#xD;
          -  not able to receive phone calls and unlimited texts on cell phone&#xD;
&#xD;
          -  not able to download and use Babyscripts phone application&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renata Sawyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Prisma Health-Upstate</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Soper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Greenville Memorial Hospital</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 3, 2020</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
    <mesh_term>Hypertension, Pregnancy-Induced</mesh_term>
    <mesh_term>HELLP Syndrome</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 9, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT04823949/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 9, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/49/NCT04823949/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

